Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias
Open accessAbstract
Rationale: Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal interstitial lung disease (ILD) characterized by abnormal extracellular matrix (ECM) remodeling. We hypothesized that ECM remodeling might result in a plasma profile of proteins specific for IPF that could distinguish patients with IPF from other idiopathic ILDs. Objectives: To identify biomarkers that might assist in distinguishing IPF from non-IPF ILD. Methods: We developed a panel of 35 ECM, ECM-related, and lung-specific analytes measured in plasma from 86 patients with IPF (derivation cohort) and in 63 patients with IPF (validation cohort). Comparison groups included patients with rheumatoid arthritis–associated ILD (RA-ILD; n = 33), patients with alternative idiopathic ILDs (a-ILD; n = 41), and healthy control subjects (n = 127). Univariable and multivariable logistic regression models identified biomarkers that differentiated patients with IPF from those with a-ILD. Both continuous and diagnostic threshold versions of biomarkers were considered; thresholds were chosen to maximize summed diagnostic sensitivity and specificity in univariate receiver-operating characteristic curve analysis. A diagnostic score was created from the most promising analytes. Measurements and Main Results: Plasma surfactant protein (SP)-D > 31 ng/ml, matrix metalloproteinase (MMP)-7 > 1.75 ng/ml, and osteopontin > 6 ng/ml each significantly distinguished patients with IPF from patients with a-ILD, both individually and in a combined index. The odds ratio for IPF when at least one analyte in the index exceeded the threshold was 4.4 (95% confidence interval, 2.0–9.7; P = 0.0003). When at least two analytes were elevated, the odds ratio for IPF increased to 5.0 (95% confidence interval, 2.2–11.5; P = 0.0002). Conclusions: A biomarker index of SP-D, MMP-7, and osteopontin enhanced diagnostic accuracy in patients with IPF compared with those with non-IPF ILD. Our data suggest that this biomarker index may improve diagnostic confidence in IPF.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A panel including MMP7, SP-D and osteopontin enhanced diagnostic accuracy in IPF versus alternative idiopathic ILDs when plasma levels of at least one analyte in the panel exceeded a threshold.
“Another study showed that a panel including MMP7, surfactant protein D (SP-D) and osteopontin (OPN) enhanced diagnostic accuracy in IPF versus alternative idiopathic ILDs when plasma levels of at least one analyte in the panel exceeded a threshold (White et al., 2016).”
From Pulmonary fibrosis: Emerging diagnostic and therapeutic strategies (2023) · cites this paper as White et al., 2016
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186 · see citing works
Self-citationSome Methods for Strengthening the Common χ 2 Tests
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001616 · Cited by 3,718 · see citing works
Tests for Linear Trends in Proportions and Frequencies
Armitage, P. (1955) · Biometrics · doi:10.2307/3001775 · Cited by 2,092 · see citing works
Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,631 · see citing works
Booth, A. J., Hadley, R., Cornett, A. M., Dreffs, A. A., Matthes, S. A., Tsui, J. L., Weiss, K., Horowitz, J. C., Fiore, V. F., Barker, T. H., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0754oc · Cited by 665 · see citing works
Self-citationMMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Rosas, I. O., Richards, T. J., Konishi, K., Zhang, Y., Gibson, K., Lokshin, A. E., Lindell, K. O., Cisneros, J., MacDonald, S. D., Pardo, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050093 · Cited by 582 · see citing works
Self-citationFibrotic extracellular matrix activates a profibrotic positive feedback loop
Parker, M. W., Rossi, D., Peterson, M., Smith, K. A., Sikström, K., White, E. S., Connett, J. E., Henke, C. A., Larsson, O. S., & Bitterman, P. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71386 · Cited by 554 · see citing works
Self-citationThe Two-Sample Trimmed t for Unequal Population Variances
Yuen, K. K. (1974) · Biometrika · doi:10.1093/biomet/61.1.165 · Cited by 542 · see citing works
Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis
Pardo, A., Gibson, K. F., Cisneros, J., Richards, T. J., Yang, Y., Becerril, C., Yousem, S., Herrera, I., Ruiz, V., Selman, M., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020251 · Cited by 492 · see citing works
Selman, M., Ruiz, V., Cabrera, S., Segura, L., Ramı́rez, R., Barrios, R. J., & Pardo, A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l562 · Cited by 426 · see citing works
Jenkins, R. G., Simpson, J. K., Saini, G., Bentley, J. H., Russell, A.-M., Braybrooke, R., Molyneaux, P. L., McKeever, T. M., Wells, A. U., Flynn, A., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00048-x · Cited by 314 · see citing works
Pulmonary Surfactant Protein D in Sera and Bronchoalveolar Lavage Fluids
Honda, Y., Kuroki, Y., Matsuura, E., Nagae, H., Takahashi, H., Akino, T., & Abe, S. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.6.8520747 · Cited by 298 · see citing works
Takahashi, H., Fujishima, T., Koba, H., Murakami, S., Kurokawa, K., Shibuya, Y., Shiratori, M., Kuroki, Y., & Abe, S. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9910080 · Cited by 291 · see citing works
Clinical Predictors of a Diagnosis of Idiopathic Pulmonary Fibrosis
Fell, C. D., Martínez, F. J., Liu, L. X., Murray, S., Han, M. K., Kazerooni, E. A., Gross, B. H., Myers, J. L., Travis, W. D., Colby, T. V., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0959oc · Cited by 243 · see citing works
Self-citationRaghu, G., Lynch, D. A., Godwin, J. D., Webb, R., Colby, T. V., Leslie, K. O., Behr, J., Brown, K. M., Egan, J. J., Flaherty, K. R., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70011-6 · Cited by 186 · see citing works
Self-citationRaghu, G., & Selman, M. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201411-2044ed · Cited by 180 · see citing works
Kropski, J. A., Pritchett, J. M., Zoz, D. F., Crossno, P. F., Markin, C. R., Garnett, E. T., Degryse, A. L., Mitchell, D. B., Polosukhin, V. V., Rickman, O. B., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1162oc · Cited by 178 · see citing works
Self-citationAcute exacerbation of interstitial pneumonia following surgical lung biopsy
Kondoh, Y., Taniguchi, H., Kitaichi, M., Yokoi, T., Johkoh, T., Oishi, T., Kimura, T., Nishiyama, O., Kato, K., & du Bois, R. M. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.02.002 · Cited by 170 · see citing works
Matrices of Physiologic Stiffness Potently Inactivate Idiopathic Pulmonary Fibrosis Fibroblasts
Marinković, A., Liu, F., & Tschumperlin, D. J. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0335oc · Cited by 162 · see citing works
Role of Osteopontin in the Pathogenesis of Bleomycin-Induced Pulmonary Fibrosis
Takahashi, F., Takahashi, K., Okazaki, T., Maeda, K., Ienaga, H., Maeda, M., Kon, S., Uede, T., & Fukuchi, Y. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.3.4293 · Cited by 160 · see citing works
Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis
Thomeer, M., Demedts, M., Behr, J., Buhl, R., Costabel, U., Flower, C. D. R., Verschakelen, J., Laurent, F., Nicholson, A. G., Verbeken, E. K., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00063706 · Cited by 152 · see citing works
Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?
López, B., González, A., Lindner, D., Westermann, D., Ravassa, S., Beaumont, J., Gallego, I., Zudaire, A., Brugnolaro, C., Querejeta, R., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt100 · Cited by 132 · see citing works
Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis
Restrepo, J. F., del Rincón, I., Battafarano, D. F., Haas, R. W., Doria, M., & Escalante, A. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-3025-8 · Cited by 123 · see citing works
Matrix Biology of Idiopathic Pulmonary Fibrosis
Thannickal, V. J., Henke, C. A., Horowitz, J. C., Noble, P. W., Roman, J., Sime, P. J., Zhou, Y., Wells, R. G., White, E. S., & Tschumperlin, D. J. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.02.003 · Cited by 117 · see citing works
Self-citationOsteopontin induces ductular reaction contributing to liver fibrosis
Wang, X., Lopategi, A., Ge, X., Lu, Y., Kitamura, N., Urtasun, R., Leung, T.-M., Fiel, M. I., & Nieto, N. (2014) · Gut · doi:10.1136/gutjnl-2013-306373 · Cited by 108 · see citing works
The Evaluation of Diagnostic Tests
Greenhouse, S. W., & Mantel, N. (1950) · Biometrics · doi:10.2307/3001784 · Cited by 91 · see citing works
Effects and regulation of osteopontin in rat hepatic stellate cells
Lee, S. H., Seo, G. S., Park, Y. N., Yoo, T. M., & Sohn, D. H. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.08.022 · Cited by 81 · see citing works
Cartilage Oligomeric Matrix Protein in Idiopathic Pulmonary Fibrosis
Vuga, L. J., Milošević, J., Pandit, K. V., Ben‐Yehudah, A., Chu, Y., Richards, T. J., Sciurba, J. C., Myerburg, M. M., Zhang, Y., Parwani, A. V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083120 · Cited by 74 · see citing works
Pardo, A., Selman, M., Ramı́rez, R., Ramos, C., Montaño, M., Stricklin, G. P., & Raghu, G. (1992) · CHEST Journal · doi:10.1378/chest.102.4.1085 · Cited by 72 · see citing works
Matsue, Y., Tsutsumi, M., Hayashi, N., Saito, T., Tsuchishima, M., Toshikuni, N., Arisawa, T., & George, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118744 · Cited by 55 · see citing works
Mechanisms of pulmonary fibrosis: role of activated myofibroblasts and NADPH oxidase
Thannickal, V. J. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s23 · Cited by 38 · see citing works
Fabre, V., Wu, H.-W., Pond‐Tor, S., Coutinho, H. M., Acosta, L. P., Jiz, M., Olveda, R. M., Cheng, L., White, E. S., Jarilla, B. R., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq099 · Cited by 32 · see citing works
Self-citationNagao, T., Okura, T., Irita, J., Jotoku, M., Enomoto, D., Desilva, V. R., Miyoshi, K., Kurata, M., Matsui, Y., Uede, T., et al. (2012) · Nephron Extra · doi:10.1159/000337330 · Cited by 21 · see citing works
Maternal Infection with Schistosoma japonicum Induces a Profibrotic Response in Neonates
McDonald, E. A., Cheng, L., Jarilla, B. R., Sagliba, M. J., Gonzal, A., Amoylen, A. J., Olveda, R. M., Acosta, L. P., Baylink, D. J., White, E. S., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01060-13 · Cited by 17 · see citing works
Self-citationJovic, S., Shikhagaie, M., Mörgelin, M., Erjefalt, J. S., Kjellström, S., & Egesten, A. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.11.010 · Cited by 13 · see citing works
Elevated serum osteopontin levels in idiopathic retroperitoneal fibrosis.
Binder, M., Christoph, S., Sehnert, B., Uhl, M., Peter, H., Voll, R. E., Warnatz, K., & Kollert, F. (2012) · PubMed · Cited by 9 · see citing works
Decreased collagenase production by fibroblasts derived from idiopathic pulmonary fibrosis.
Pardo, A., & Selman, M. (1992) · PubMed · Cited by 5 · see citing works
Extracellular Matrix Remodeling in Idiopathic Pulmonary Fibrosis
Pardo, A., & Selman, M. (2001) · CHEST Journal · doi:10.1378/chest.120.1_suppl.s77 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103 · see citing works
Self-citationLederer, D. J., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705751 · Cited by 2,056 · see citing works
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.052 · Cited by 1,261 · see citing works
“SASP factors that had been associated with frailty (IL6, MCP-1, activin A, apelin) [27–30] or had been reported to have prognostic or diagnostic potential in IPF (MMP1, MMP7, osteopontin) [31,32] were further validated by single target enzyme-linked immunosorbent assays (ELISA).”
BackgroundMartinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388 · see citing works
Jenkins, G. R., Moore, B. B., Chambers, R. C., Eickelberg, O., Königshoff, M., Kolb, M. R. J., Laurent, G. J., Nanthakumar, C. B., Olman, M. A., Pardo, A., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0096st · Cited by 446 · see citing works
Self-citationIdiopathic Pulmonary Fibrosis (IPF): An Overview
Barratt, S. L., Creamer, A. W., Hayton, C., & Chaudhuri, N. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7080201 · Cited by 390 · see citing works
Idiopathic pulmonary fibrosis: state of the art for 2023
Podolanczuk, A. J., Thomson, C. C., Remy-Jardin, M., Richeldi, L., Martinez, F. J., Kolb, M., & Raghu, G. (2023) · European Respiratory Journal · doi:10.1183/13993003.00957-2022 · Cited by 359 · see citing works
What's in a name? That which we call IPF, by any other name would act the same
Wells, A. U., Brown, K. K., Flaherty, K. R., Kolb, M. R. J., & Thannickal, V. J. (2018) · European Respiratory Journal · doi:10.1183/13993003.00692-2018 · Cited by 354 · see citing works
Self-citationLey, B., Newton, C. A., Arnould, I. S., Elicker, B. M., Henry, T. S., Vittinghoff, E., Golden, J. A., Jones, K. D., Batra, K., Torrealba, J. R., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30216-3 · Cited by 298 · see citing works
An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices
Alsafadi, H. N., Staab-Weijnitz, C. A., Lehmann, M., Lindner, M., Peschel, B., Königshoff, M., & Wagner, D. E. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00084.2017 · Cited by 263 · see citing works
Maher, T. M., Oballa, E., Simpson, J. K., Porte, J., Habgood, A., Fahy, W. A., Flynn, A., Molyneaux, P. L., Braybrooke, R., Divyateja, H., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30430-7 · Cited by 271 · see citing works
Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis
Nureki, S., Tomer, Y., Venosa, A., Katzen, J. B., Russo, S. J., Jamil, S., Barrett, M., Nguyen, V., Kopp, M. C., Mulugeta, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99287 · Cited by 249 · see citing works
Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis
Meyer, K. C. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1312346 · Cited by 226 · see citing works
Surfactant Protein D in Respiratory and Non-Respiratory Diseases
Sørensen, G. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00018 · Cited by 220 · see citing works
Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight
Lamort, A., Giopanou, I., Psallidas, I., & Stathopoulos, G. T. (2019) · Cells · doi:10.3390/cells8080815 · Cited by 166 · see citing works
Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects
Li, L., & Kan, L. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.12.042 · Cited by 148 · see citing works
Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Guiot, J., Moermans, C., Henket, M., Corhay, J.-L., & Louis, R. (2017) · Lung · doi:10.1007/s00408-017-9993-5 · Cited by 147 · see citing works
Precision medicine advances in idiopathic pulmonary fibrosis
Karampitsakos, Τ., Juan-Guardela, B. M., Τzouvelekis, Α., & Herazo‐Maya, J. D. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104766 · Cited by 147 · see citing works
The role of periostin in lung fibrosis and airway remodeling
O’Dwyer, D. N., & Moore, B. B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2649-z · Cited by 144 · see citing works
Self-citationValidation of the prognostic value of <scp>MMP</scp>‐7 in idiopathic pulmonary fibrosis
Tzouvelekis, A., Herazo‐Maya, J. D., Slade, M., Chu, J., Deiuliis, G., Ryu, C., Li, Q., Sakamoto, K., Ibarra, G., Pan, H., et al. (2017) · Respirology · doi:10.1111/resp.12920 · Cited by 130 · see citing works
Bauer, Y., White, E. S., de Bernard, S., Cornelisse, P., Leconte, I., Morganti, A., Roux, S., & Nayler, O. (2017) · ERJ Open Research · doi:10.1183/23120541.00074-2016 · Cited by 139 · see citing works
Self-citationInoue, Y., Kaner, R. J., Guiot, J., Maher, T. M., Tomassetti, S., Moiseev, S., Kuwana, M., & Brown, K. K. (2020) · Chest · doi:10.1016/j.chest.2020.03.037 · Cited by 133 · see citing works
Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis
Mahalanobish, S., Saha, S., Dutta, S., & Sil, P. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104591 · Cited by 125 · see citing works
An SFTPC BRICHOS mutant links epithelial ER stress and spontaneous lung fibrosis
Katzen, J. B., Wagner, B. D., Venosa, A., Kopp, M. C., Tomer, Y., Russo, S. J., Headen, A. C., Basil, M. C., Stark, J. M., Mulugeta, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126125 · Cited by 122 · see citing works
Biomarkers in idiopathic pulmonary fibrosis
Drakopanagiotakis, F., Wujak, L., Wygrecka, M., & Markart, P. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.023 · Cited by 132 · see citing works
Kronzer, V. L., Huang, W., Dellaripa, P. F., Huang, S., Feathers, V. L., Lü, B., Iannaccone, C. K., Gill, R. R., Hatabu, H., Nishino, M., et al. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.200863 · Cited by 113 · see citing works
Self-citationThe diagnosis of idiopathic pulmonary fibrosis: current and future approaches
Martínez, F. J., Chisholm, A., Collard, H. R., Flaherty, K. R., Myers, J. L., Raghu, G., Walsh, S. L. F., White, E. S., & Richeldi, L. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30325-3 · Cited by 108 · see citing works
Self-citationUsual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine Learning
Pankratz, D. G., Choi, Y., Imtiaz, U., Fedorowicz, G. M., Anderson, J. D., Colby, T. V., Myers, J. L., Lynch, D. A., Brown, K. K., Flaherty, K. R., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201612-947oc · Cited by 96 · see citing works
Self-citationBiomarker signatures for progressive idiopathic pulmonary fibrosis
Clynick, B., Corte, T. J., Jo, H. E., Stewart, I., Glaspole, I. N., Grainge, C., Maher, T. M., Navaratnam, V., Hubbard, R., Hopkins, P. M. A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01181-2021 · Cited by 86 · see citing works
O’Dwyer, D. N., Ashley, S. L., & Moore, B. B. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00221.2016 · Cited by 89 · see citing works
Self-citationAdegunsoye, A., Alqalyoobi, S., Linderholm, A., Bowman, W. S., Lee, C. T., Pugashetti, J. V., Sarma, N., Ma, S.-F., Haczku, A., Sperling, A., et al. (2020) · Chest · doi:10.1016/j.chest.2020.04.066 · Cited by 82 · see citing works
Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis
Wang, K., Ju, Q., Cao, J., Tang, W., & Zhang, J. (2017) · Medicine · doi:10.1097/md.0000000000007083 · Cited by 81 · see citing works
Glick, D., Lyen, S. M., Kandel, S. M., Shapera, S., Le, L. W., Lindsay, P. E., Wong, O., Bezjak, A., Brade, A. M., Cho, J., et al. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.06.021 · Cited by 80 · see citing works
Bowman, W. S., Echt, G., & Oldham, J. M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.680997 · Cited by 76 · see citing works
Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions
Stainer, A., Faverio, P., Busnelli, S., Catalano, M., Zoppa, M. D., Marruchella, A., Pesci, A., & Luppi, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126255 · Cited by 77 · see citing works
Huang, S., Kronzer, V. L., Dellaripa, P. F., Deane, K. D., Bolster, M. B., Nagaraja, V., Khanna, D., Doyle, T. J., & Sparks, J. A. (2020) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-020-00160-z · Cited by 75 · see citing works
Self-citationElhaï, M., Avouac, J., & Allanore, Y. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.01.006 · Cited by 71 · see citing works
Johnson, C. R. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000380 · Cited by 64 · see citing works
Sisson, T. H., Christensen, P. J., Muraki, Y., Dils, A. J., Chibucos, L. N., Subbotina, N., Tohyama, K., Horowitz, J. C., Matsuo, T., Bailie, M. B., et al. (2018) · Physiological Reports · doi:10.14814/phy2.13753 · Cited by 62 · see citing works
Kass, D. J., Nouraie, M. S., Glassberg, M. K., Ramreddy, N., Fernandez, K., Harlow, L. A., Zhang, Y., Chen, J., Kerr, G. S., Reimold, A. M., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41123 · Cited by 61 · see citing works
Self-citationEnomoto, Y., Matsushima, S., Shibata, K., Aoshima, Y., Yagi, H., Meguro, S., Kawasaki, H., Kosugi, I., Fujisawa, T., Enomoto, N., et al. (2018) · Clinical Science · doi:10.1042/cs20180435 · Cited by 60 · see citing works
Maher, T. M., Corte, T. J., Fischer, A., Kreuter, M., Lederer, D. J., Molina‐Molina, M., Axmann, J., Kirchgaessler, K.-U., & Cottin, V. (2018) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2018-000289 · Cited by 59 · see citing works
D’Alessandro‐Gabazza, C. N., Yasuma, T., Kobayashi, T., Toda, M., Abdel-Hamid, A. M., Fujimoto, H., Hataji, O., Nakahara, H., Takeshita, A., Nishihama, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29064-3 · Cited by 58 · see citing works
Pulmonary fibrosis: Emerging diagnostic and therapeutic strategies
Selvarajah, B., Platé, M., & Chambers, R. C. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101227 · Cited by 57 · see citing works
Tomos, I. P., Tzouvelekis, A., Aidinis, V., Manali, E. D., Bouros, E., Bouros, D. E., & Papiris, S. A. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1300533 · Cited by 51 · see citing works
Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis
Buendía-Roldán, I., Ruiz, V., Sierra, P., Montes, E., Ramı́rez, R., Vega, A., Salgado-Aguayo, A. R., Vargas, M. H., Mejía, M. E., Pardo, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168552 · Cited by 52 · see citing works
Reininger, D., Fundel‐Clemens, K., Mayr, C. H., Wollin, L., Laemmle, B., Quast, K., Nickolaus, P., & Herrmann, F. E. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17303 · Cited by 48 · see citing works
“…such as MMP-7, OPN, sICAM-1 and CTGF. MMP-7 and OPN are described as predictive and prognostic biomarkers for IPF, with sICAM-1 and CTGF protein levels being elevated in the blood serum and plasma of IPF patients (Guiot et al., 2017; Kono et al., 2011; Tzouvelekis et al., 2017; White et al., 2016).”
Approaching Clinical Trials in Childhood Interstitial Lung Disease and Pediatric Pulmonary Fibrosis
Deterding, R. R., DeBoer, E. M., Cidon, M. J., Robinson, T. E., Warburton, D., Deutsch, G. H., & Young, L. R. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0544ci · Cited by 47 · see citing works
The critical role of osteopontin (OPN) in fibrotic diseases
Tang, Z., Xia, Z., Wang, X., & Liu, Y. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.08.007 · Cited by 47 · see citing works
iTRAQ-Based Proteomics Reveals Novel Biomarkers for Idiopathic Pulmonary Fibrosis
Niu, R. L., Liu, Y., Zhang, Y., Zhang, Y., Wang, H., Wang, Y., Wang, W., & Li, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170741 · Cited by 47 · see citing works
Armstrong, H. F., Podolanczuk, A. J., Barr, R. G., Oelsner, E. C., Kawut, S. M., Hoffman, E. A., Tracy, R. P., Kaminski, N., McClelland, R. L., & Lederer, D. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0254oc · Cited by 47 · see citing works
Tsitoura, E., Trachalaki, A., Vasarmidi, E., Mastrodemou, S., Margaritopoulos, G. A., Kokosi, M. A., Fanidis, D., Galaris, A., Aidinis, V., Renzoni, E. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645548 · Cited by 44 · see citing works
Cell‐specific expression of runt‐related transcription factor 2 contributes to pulmonary fibrosis
Mümmler, C., Burgy, O., Hermann, S., Mutze, K., Günther, A., & Königshoff, M. (2017) · The FASEB Journal · doi:10.1096/fj.201700482r · Cited by 43 · see citing works
S2K Guideline for Diagnosis of Idiopathic Pulmonary Fibrosis
Behr, J., Günther, A., Bonella, F., Dinkel, J., Fink, L., Geiser, T., Geissler, K. H., Gläser, S., Handzhiev, S., Jonigk, D. D., et al. (2021) · Respiration · doi:10.1159/000512315 · Cited by 40 · see citing works
Biomarkers of cellular senescence in idiopathic pulmonary fibrosis
Aversa, Z., Atkinson, E. J., Carmona, E. M., White, T. A., Heeren, A. A., Jachim, S. K., Zhang, X., Cummings, S. R., Chiarella, S. E., LIMPER, A. H., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02403-8 · Cited by 39 · see citing works
Xue, M., Guo, Z., Cai, C., Sun, B., & Wang, H. (2019) · Respiration · doi:10.1159/000503689 · Cited by 39 · see citing works
Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis
Inchingolo, R., Varone, F., Sgalla, G., & Richeldi, L. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1553620 · Cited by 37 · see citing works
Shimodaira, T., Matsuda, K., Uchibori, T., Sugano, M., Uehara, T., & Honda, T. (2018) · Cytokine · doi:10.1016/j.cyto.2018.04.025 · Cited by 36 · see citing works
Pirfenidone Clinical Study Group in Japan, Ikeda, K., Chiba, H., Nishikiori, H., Azuma, A., Kondoh, Y., Ogura, T., Taguchi, Y., Ebina, M., Sakaguchi, H., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01582-y · Cited by 36 · see citing works
Zhang, J., Ren, P., Wang, Y., Feng, S., Wang, C., Shen, X., Weng, C., Lang, X., Chen, Z., Jiang, H., et al. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000477132 · Cited by 33 · see citing works
Effect of positive airway pressure therapy of obstructive sleep apnea on circulating Angiopoietin-2
Gottlieb, D. J., Lederer, D. J., Kim, J. S., Tracy, R. P., Gao, S., Redline, S. S., & Jelić, S. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.05.007 · Cited by 34 · see citing works
Utility of serological biomarker’ panels for diagnostic accuracy of interstitial lung diseases
Bergantini, L., d’Alessandro, M., Vietri, L., Rana, G. D., Cameli, P., Acerra, S., Sestini, P., & Bargagli, E. (2020) · Immunologic Research · doi:10.1007/s12026-020-09158-0 · Cited by 31 · see citing works
Fraz, M. S. A., Michelsen, A. E., Moe, N., Aaløkken, T. M., Macpherson, M. E., Nordøy, I., Aukrust, P., Taraldsrud, E., Holm, A. M., Ueland, T., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01318-1 · Cited by 31 · see citing works
The Dawn of Precision Medicine in Fibrotic Interstitial Lung Disease
Karampitsakos, Τ., Tourki, B., & Herazo‐Maya, J. D. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.10.042 · Cited by 31 · see citing works
Current issues in rheumatoid arthritis-associated interstitial lung disease
Kelly, C. A., Emery, P., & Dieudé, P. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00250-2 · Cited by 29 · see citing works
Rodríguez, L. R., Tomer, Y., Carson, P., Dimopoulos, T. T., Zhao, M., Chavez, K., Iyer, S., Huang, L., Ebert, C., Sereda, L., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0203ma · Cited by 26 · see citing works
Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis
Zhu, W., Liu, C., Tan, C., & Zhang, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23543 · Cited by 27 · see citing works
Jee, A. S., Stewart, I. D., Youssef, P. P., Adelstein, S., Lai, D., Hua, S., Stevens, W., Proudman, S., Ngian, G., Glaspole, I., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42491 · Cited by 26 · see citing works
Sato, Y., Tanino, Y., Wang, X., Nikaido, T., Sato, S., Misa, K., Togawa, R., Frevert, C. W., & Munakata, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176789 · Cited by 25 · see citing works
Maldonado, M., Buendía-Roldán, I., Vicens‐Zygmunt, V., Planas‐Cerezales, L., Molina‐Molina, M., Selman, M., & Pardo, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203779 · Cited by 24 · see citing works
Predictors of long-term prognosis in rheumatoid arthritis-related interstitial lung disease
Chen, J., Chen, Y., Liu, D., Lin, Y., Zhu, L., Song, S., Hu, Y., Liang, T., Liu, Y., Liu, W. Q., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-13474-w · Cited by 23 · see citing works
Nonspecific Interstitial Pneumonia
Teoh, A. K. Y., & Corte, T. J. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1708499 · Cited by 23 · see citing works
d’Alessandro, M., Bergantini, L., Torricelli, E., Cameli, P., Lavorini, F., Pieroni, M., Refini, R. M., Sestini, P., & Bargagli, E. (2021) · Cancers · doi:10.3390/cancers13030539 · Cited by 22 · see citing works
Advances in idiopathic pulmonary fibrosis diagnosis and treatment
Liu, H., Shen, J., & He, C. (2025) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2025.02.001 · Cited by 21 · see citing works
Nakanishi, T., Cerani, A., Forgetta, V., Zhou, S., Allen, R. J., Leavy, O. C., Koido, M., Assayag, D., Jenkins, G. R., Wain, L. V., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.03979-2020 · Cited by 21 · see citing works
Moon, J., Lee, J. S., Yoon, Y. I., Chang, S. H., Lee, Y. A., Ha, Y., Kang, E. H., Park, Y., Lee, H., Choe, J., et al. (2021) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2021.28.4.234 · Cited by 21 · see citing works
Idiopathic pulmonary fibrosis: Diagnosis, biomarkers and newer treatment protocols
Patel, H., Shah, J. R., Patel, D., Avanthika, C., Jhaveri, S., & Gor, K. (2022) · Disease-a-Month · doi:10.1016/j.disamonth.2022.101484 · Cited by 21 · see citing works
Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
Drakopanagiotakis, F., Markart, P., & Steiropoulos, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210196 · Cited by 21 · see citing works
Pulito‐Cueto, V., Atienza‐Mateo, B., Batista-Liz, J., Mora-Gil, M. S., Cuesta, V. M. M., Fernandez, D. I., Cuervo, S. I., Portilla, C. A., Blanco, R., & López‐Mejías, R. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01128-2 · Cited by 22 · see citing works
Unclassifiable interstitial lung disease
Guler, S. A., & Ryerson, C. J. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000509 · Cited by 20 · see citing works
Diagnosis of early idiopathic pulmonary fibrosis: current status and future perspective
Wang, X., Xu, X., Hou, Y., Zhang, H., Han, W., Sun, J., & Feng, L. (2025) · Respiratory Research · doi:10.1186/s12931-025-03270-1 · Cited by 19 · see citing works
Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis
Wang, Q., Xie, Z., Wan, N., Yang, L., Jin, Z., Jin, F., Huang, Z., Chen, M., Wang, H., & Feng, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002171 · Cited by 19 · see citing works
Idiopathic pulmonary fibrosis (IPF): Diagnostic routes using novel biomarkers
Bartold, K., Iskierko, Z., Sharma, P. S., Lin, H., & Kutner, W. (2024) · Biomedical Journal · doi:10.1016/j.bj.2024.100729 · Cited by 19 · see citing works
Qaseem, A. S., Singh, I., Pathan, A. A., Layhadi, J. A., Parkin, R. V., Alexandra, F., Durham, S. R., Kishore, U., & Shamji, M. H. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0225oc · Cited by 19 · see citing works
César, E. C., López, L. L., Lara, E., Juan, M. V. H.-S., Romero, C. P., Palencia, J. L. R. S., Martín‐Montañez, E., & Garcia‐Fernandez, M. I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143167 · Cited by 19 · see citing works
The role of autophagy in fibrosis: Mechanisms, progression and therapeutic potential (Review)
Chen, Y., Wang, Z., Ma, Q., & Sun, C. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5502 · Cited by 21 · see citing works
Aoshima, Y., Enomoto, Y., Muto, S., Meguro, S., Kawasaki, H., Kosugi, I., Fujisawa, T., Enomoto, N., Inui, N., Nakamura, Y., et al. (2021) · Lung · doi:10.1007/s00408-021-00440-y · Cited by 18 · see citing works
Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?
Singh, V., Ulasov, I., Gupta, S., Singh, A., Roy, V. K., & Kharwar, R. K. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436180.3 · Cited by 17 · see citing works
Cottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100948 · Cited by 17 · see citing works
Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
Tzilas, V., Τzouvelekis, Α., Chrysikos, S., Papiris, S. A., & Bouros, D. E. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00151 · Cited by 17 · see citing works
Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia
Miura, Y., Lam, M., Bourke, J. E., & Kanazawa, S. (2021) · Life Science Alliance · doi:10.26508/lsa.202101059 · Cited by 17 · see citing works
Pulmonary fibrosis, part II: state-of-the-art patient management
Meyer, K. C. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1312347 · Cited by 16 · see citing works
He, X., Ji, J., Zheng, D., Luo, Z., Luo, L., & Guo, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1450798 · Cited by 15 · see citing works
Zhang, S., Zhang, L., Wang, L., Wang, H., Wu, J., Cai, H., Mo, C., & Yang, J. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1246983 · Cited by 15 · see citing works
Liao, Y., Peng, X., Yang, Y., Zhou, G., Chen, L., Yang, Y., Li, H., Chen, X., Guo, S., Zuo, Q., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2409352 · Cited by 15 · see citing works
Šterclová, M., Smětáková, M., Stehlík, L., Skibová, J., & Vašáková, M. (2019) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-019-0175-6 · Cited by 15 · see citing works
Xia, Y., Lei, C., Yang, D., & Luo, H. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107369 · Cited by 14 · see citing works
Nizamoglu, M., & Burgess, J. K. (2021) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-021-00031-2 · Cited by 14 · see citing works
Ma, M., Chu, Z., Quan, H., Li, H., Zhou, Y., Han, Y., Li, K., Pan, W., Wang, D., Yan, Y., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1524654 · Cited by 14 · see citing works
Biomarkers and their potential functions in idiopathic pulmonary fibrosis
Ni, S., Song, M. S., Guo, W., Guo, T., Shen, Q., & Peng, H. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1745066 · Cited by 13 · see citing works
- Authors
- White, E. S., Xia, M., Murray, S., Dyal, R., Flaherty, C. M., Flaherty, K. R., Moore, B. B., Cheng, L., Doyle, T. J., Villalba, J., Dellaripa, P. F., Rosas, I. O., Kurtis, J. D., & Martinez, F. J.
- Affiliations
- University of Michigan (US)
- Brown University (US)
- Division of Pulmonary and Critical Care and
- Brigham and Women's Hospital (US)
- Joan and Sanford Weill Department of Internal Medicine, Weill Cornell Medical College New York, New York
- Corresponding author
- White, Eric S.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11
- Volume
- 194
- Issue
- 10
- Pages
- 1242-1251
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC5114439
- OpenAlex
- W2346999058
- Cited by
- 180
- References
- 39
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 15 · 2023: 17 · 2022: 9 · 2021: 23 · 2020: 18 · 2019: 17 · 2018: 19 · 2017: 28 · 2016: 7
- FWCI
- 21.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01 HL085083, R01 HL109118, RC2 HL101740, K23 HL119558, P01HL114501, R01HL130974, HL115618)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Pathology and Forensic Medicine › Systemic Sclerosis and Related Diseases
- Keywords
- idiopathic pulmonary fibrosis, idiopathic interstitial lung disease, plasma biomarkers, surfactant protein D, matrix metalloproteinase-7, osteopontin, extracellular matrix remodeling, rheumatoid arthritis-associated interstitial lung disease
- MeSH terms
- Diagnosis, Differential, Female, Humans, Male, Middle Aged, ROC Curve, Sensitivity and Specificity, Cohort Studies, Biomarkers, Matrix Metalloproteinase 7, Pulmonary Surfactant-Associated Protein D, Osteopontin, Idiopathic Interstitial Pneumonias, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
